Position in ENOV
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$1,794,679
+$273,402 QoQ
Shares Held
78,887
+38.1% QoQ
Ownership
0.137%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2022
9 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in ENOV Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026CAPITAL FUND MANAGEMENT S.A. holds $222,994,073 across 14 Medical Devices names. ENOV ranks #9 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BSX |
Boston Scientific Corp
|
1,665,947 | $104,538,174 | |
| 2 | SYK |
Stryker Corp
|
159,450 | $52,393,675 | |
| 3 | DXCM |
Dexcom Inc
|
532,396 | $33,434,468 | |
| 4 | PODD |
Insulet Corp
|
29,770 | $6,246,936 | |
| 5 | ABT |
Abbott Laboratories
|
59,488 | $6,107,632 | |
| 6 | INSP |
Inspire Medical Systems, Inc.
|
109,015 | $5,622,993 | |
| 7 | MDT |
Medtronic plc
|
61,660 | $5,342,839 | |
| 8 | GMED |
Globus Medical Inc
|
41,548 | $3,579,775 |
All Filings in ENOV
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,794,679 | 78,887 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $1,521,277 | 57,105 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $2,640,793 | 87,040 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $1,682,213 | 53,642 | Shares | Sole | 2025-08-13 | |
| 2024-03-31 | $2,404,824 | 38,508 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,380,612 | 24,645 | Shares | Sole | 2024-02-14 | |
| 2023-06-30 | $1,122,420 | 17,505 | Shares | Sole | 2023-08-14 | |
| 2022-06-30 | $693,000 | 12,600 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $585,669 | 14,719 | Shares | Sole | 2022-05-12 | |
| No filing history on record for this holder in this stock. | ||||||